Public trial registry of the CCC-Munich

Trial CAIN457ADE01T (Secukinomab)

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
CAIN457ADE01T (Secukinomab)
World
Full title
:

Pilotstudie zum Einsatz von anti-IL-17 (Secukinumab) bei der Behandlung von Pyoderma gangraenosum CAIN457ADE01T

World
Responsible organization
:
Hautklinik MRI Ismanínger Str. 22 81675 München Germany
Indications
Classification Code Description
ICD-10-GM L88 Pyoderma gangraenosum
Trial design
World
Phase
:
I/II
Status
World
Status
:
Recruitment active
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy
:

Zielgerichtet

Participants
Function Prename Surname Organization
World Responsible contact Kilian Eyerich Hautklinik MRI Ismanínger Str. 22 81675 München Germany Magnifier